2017 News Releases

Keyword Search
 
2017 | 2016 | 2015 | 2014
DateTitle 
09/20/17Lombard Medical Appoints Jonathan Hornsby as Vice President, Sales & Marketing
Veteran European Sales Manager of Endovascular Aneurysm Repair Market with Extensive Clinical and UK Experience OXFORDSHIRE, England--(BUSINESS WIRE)--Sep. 20, 2017-- Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced the appointment of Jonathan Hornsby as Vice President, Sales & Marketing, effective immediately. Jonathan Hornsby brings over ... 
Printer Friendly Version
09/13/17Lombard Medical Announces Completion of Restructuring and Implementation of Strategic Plan to Achieve Profitability
OXFORDSHIRE, England--(BUSINESS WIRE)--Sep. 13, 2017-- Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced completion of a restructuring following the implementation of its new strategy to focus sales efforts in the UK, Japan and China, and reduce operating and manufacturing costs in order to achieve cash flow breakeven in the near term. The restructu... 
Printer Friendly Version
05/15/17Lombard Medical Announces First Patient Enrolled and Treated in the ALTITUDE Registry for the Altura® Stent Graft System
OXFORDSHIRE, U.K.--(BUSINESS WIRE)--May 15, 2017-- Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced that it has enrolled and treated the first patient in its global registry to evaluate its Altura® Endograft System. The ALTITUDE registry (ALTura Impact on the Treatment of Abdominal Aortic Aneurysms Using a Novel D-stent EVAR Design) is being conduc... 
Printer Friendly Version
05/04/17Lombard Medical's Endovascular Product Portfolio Presented at Scientific Sessions of the 39th Annual Charing Cross International Symposium
OXFORDSHIRE, U.K.--(BUSINESS WIRE)--May 4, 2017-- Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced that its portfolio of endovascular stent graft systems, Altura® and Aorfix™, were featured in scientific presentations at the 39th annual Charing Cross International Symposium in London on April 25 - 26. Altura Presentations Altura clinical da... 
Printer Friendly Version
04/20/17Lombard Medical Appoints New CEO
OXFORDSHIRE, England--(BUSINESS WIRE)--Apr. 20, 2017-- Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced that Kurt Lemvigh has been appointed as its new Chief Executive Officer, effective immediately. Lemvigh is a veteran medical device executive with over 30 years of experience creating profitable growth. He currently resides in the U.K. and has he... 
Printer Friendly Version
04/18/17Lombard Medical Reports 2016 Fourth Quarter, Full Year Financial Results
OXFORDSHIRE, U.K.--(BUSINESS WIRE)--Apr. 18, 2017-- Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair of abdominal aortic aneurysms, today reported financial results for the fourth quarter and year ended December 31, 2016. Recent Operational Highlights The signing of a strategic partnership with MicroPort Scientific Corporation (HK: 0853), a leading global manufacture... 
Printer Friendly Version
04/18/17Lombard Medical’s CEO Steps Down
OXFORDSHIRE, England--(BUSINESS WIRE)--Apr. 18, 2017-- Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced that Simon Hubbert has stepped down from his position as CEO on April 18 after serving in the role for more than six years. A search is underway for a successor and an announcement is expected in due course. Hubbert joined Lombard during 2010 and... 
Printer Friendly Version
04/03/17Lombard Medical and MicroPort Scientific Corporation Finalize Strategic Partnership Agreements
Operational Foundation Established for Improved Gross Margins and Access to the Fast-Growing China Endovascular Market OXFORDSHIRE, U.K. & SHANGHAI--(BUSINESS WIRE)--Apr. 3, 2017-- Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair, and MicroPort Scientific Corporation (HK: 0853), a leading global manufacturer and marketer of a diversified portfolio of medical devices, today announced th... 
Printer Friendly Version
02/07/17Lombard Medical Announces Successful Completion of First 15 Cases in Japan for IntelliFlex™ LP Delivery System for the Aorfix™ Endovascular Stent Graft
OXFORDSHIRE, England--(BUSINESS WIRE)--Feb. 7, 2017-- Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that physicians in Japan have successfully treated the first 15 patients using its innovative new IntelliFlex™ LP Delivery System for the Aorfix™ Endovascular Stent Graft since launch on February 1, 2017. Aorfix with IntelliF... 
Printer Friendly Version
01/05/17Lombard Medical Announces Regulatory Approval in Japan for IntelliFlex™ LP Delivery System for the Aorfix™ Abdominal Aortic Aneurysm Endovascular Stent Graft
Exclusive Japanese Partner Medico’s Hirata Anticipates Market Share Gain Following Launch in Early 2017 OXFORDSHIRE, England--(BUSINESS WIRE)--Jan. 5, 2017-- Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced approval from the Japanese Ministry of Health, Labour and Welfare for its IntelliFlex™ Low Profile (LP) Delivery System for t... 
Printer Friendly Version